Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentISWI-type complex

BAZ2A BPTF

6.33e-0514182GO:0031010
GeneOntologyCellularComponentcell projection membrane

PSD3 MUC4 ROBO2 PLXND1

4.34e-04431184GO:0031253
GeneOntologyCellularComponentleading edge membrane

PSD3 ROBO2 PLXND1

7.30e-04210183GO:0031256
DomainDDT

BAZ2A BPTF

5.26e-064182PF02791
DomainDDT

BAZ2A BPTF

8.76e-065182SM00571
DomainDDT_dom

BAZ2A BPTF

8.76e-065182IPR018501
DomainWSD

BAZ2A BPTF

8.76e-065182PF15613
DomainWHIM1

BAZ2A BPTF

8.76e-065182PF15612
DomainWHIM1_dom

BAZ2A BPTF

8.76e-065182IPR028942
DomainWHIM2_dom

BAZ2A BPTF

8.76e-065182IPR028941
DomainDDT

BAZ2A BPTF

1.31e-056182PS50827
DomainBromodomain_CS

BAZ2A BPTF

2.81e-0426182IPR018359
DomainBROMODOMAIN_1

BAZ2A BPTF

5.73e-0437182PS00633
DomainBromodomain

BAZ2A BPTF

6.04e-0438182PF00439
DomainBROMODOMAIN_2

BAZ2A BPTF

7.04e-0441182PS50014
DomainBROMO

BAZ2A BPTF

7.38e-0442182SM00297
DomainBromodomain

BAZ2A BPTF

7.38e-0442182IPR001487
Domain-

BAZ2A BPTF

7.38e-04421821.20.920.10
DomainPHD

BAZ2A BPTF

2.34e-0375182PF00628
DomainZnf_PHD-finger

BAZ2A BPTF

2.59e-0379182IPR019787
DomainPHD

BAZ2A BPTF

3.27e-0389182SM00249
DomainZnf_PHD

BAZ2A BPTF

3.41e-0391182IPR001965
DomainZF_PHD_2

BAZ2A BPTF

3.71e-0395182PS50016
DomainZF_PHD_1

BAZ2A BPTF

3.79e-0396182PS01359
DomainZnf_FYVE_PHD

BAZ2A BPTF

8.67e-03147182IPR011011
DomainRRM

RBM5 TNRC6A

1.82e-02217182SM00360
DomainRRM_dom

RBM5 TNRC6A

1.98e-02227182IPR000504
DomainRRM

RBM5 TNRC6A

2.03e-02230182PS50102
Domain-

RBM5 TNRC6A

2.27e-022441823.30.70.330
Pubmed

Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival.

PSD3 PCM1

1.52e-06418216270321
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

RBM5 USP42 NUP43 BAZ2A TTF2 BPTF

3.31e-05129418630804502
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

MTUS1 NUP43 TTF2 PCM1 TNRC6A

5.76e-0585318528718761
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

USP42 MUC4 BPTF TNRC6A

8.60e-0546918427634302
Pubmed

Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon.

MUC4 ATP12A

1.32e-043318216618389
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

MTUS1 ROBO2 PLXND1 TNRC6A

1.37e-0452918414621295
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

BAZ2A TTF2 BPTF PCM1

1.58e-0454918438280479
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

MTUS1 PCM1 TNRC6A

1.63e-0420918336779422
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

MTUS1 BAZ2A BPTF PCM1 TNRC6A

2.04e-04111618531753913
Pubmed

TrkB-dependent EphrinA reverse signaling regulates callosal axon fasciculate growth downstream of Neurod2/6.

ROBO2 PLXND1

2.70e-044718235462405
Pubmed

SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.

RIOX2 NUP43 BPTF

2.76e-0425018333536335
Pubmed

Nolz1 expression is required in dopaminergic axon guidance and striatal innervation.

ROBO2 PLXND1

3.70e-045518232561725
Pubmed

Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.

RBM5 USP42 PCM1 TNRC6A

4.49e-0472318434133714
Pubmed

A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.

NUP43 ROBO2 TNRC6A

4.80e-0430218330561431
CytobandEnsembl 112 genes in cytogenetic band chr8p22

PSD3 MTUS1 PCM1

8.12e-0747183chr8p22
GeneFamilyPHD finger proteins

BAZ2A BPTF

1.84e-039013288
CoexpressionAtlasdev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000

RIOX2 HSF2 NUP43 BAZ2A

5.70e-05258184gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

RGS7BP PSD3 MUC4 ATP12A

1.06e-06198184af07a970afaa435c6433bb5c1cbff4c67af350c7
ToppCell(08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition

MTUS1 MUC4 BPTF

2.23e-05138183817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCelldroplet-Fat-Bat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS7BP RIOX2 HSF2

4.00e-05168183794035cb63353a7d02fd9939deb5b4d075c9d95a
ToppCelldroplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS7BP RIOX2 HSF2

4.00e-051681836fddc957a0503455d8c165862b5eb8e5fdb8a510
ToppCelldroplet-Fat-Bat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS7BP RIOX2 HSF2

4.00e-051681831e23b634f96e88b976a523ca1f3fc08f6fe9b239
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RGS7BP NUP43 BAZ2A

4.22e-051711832a34685f7d83d1cf9a88d304173cbca868c5f9fd
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RGS7BP MUC4 ATP12A

4.45e-0517418342f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

RGS7BP ROBO2 ATP12A

4.52e-05175183067c7d89cfdf6ebf70692df64b9b79d752f093dd
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

RGS7BP ROBO2 ATP12A

4.52e-05175183b80fe906043b3cb0b3ba761aadc9dc1c364aa1bf
ToppCellnucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

RGS7BP MUC4 ATP12A

4.68e-05177183779ba86f53650772755b52460be03f18bb204e55
ToppCellnucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

RGS7BP MUC4 ATP12A

4.68e-051771830f210cfb61b873c5fd77dc17eadf4d017306500e
ToppCelldroplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS7BP MTUS1 PLXND1

5.00e-05181183a53f05c4c47465ee62e353716456bd09ab464b23
ToppCellBAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

RGS7BP MUC4 ATP12A

5.00e-0518118358651853f9c715075889856793df66ebe00c04f1
ToppCellBAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RGS7BP MUC4 ATP12A

5.00e-05181183faff2a34e391d053a17c926540e6cb46d94dd629
ToppCellBAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RGS7BP MUC4 ATP12A

5.00e-051811835a9c332c0bf07cc20eaf8cf77b45e73668a6467d
ToppCellBAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

RGS7BP MUC4 ATP12A

5.00e-05181183488a517f6e5543b648a2e72e0e04332fad776de6
ToppCelldroplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS7BP MTUS1 PLXND1

5.16e-05183183709a486154b3157427deb3b8886b63ac39ea42dd
ToppCelldroplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS7BP MTUS1 PLXND1

5.16e-05183183dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7
ToppCellControl-Epithelial-Goblet|World / Disease state, Lineage and Cell class

MTUS1 MUC4 ATP12A

5.33e-051851839a793e6016295a63820e9d7563f195494ac692e7
ToppCellCOPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class

MTUS1 MUC4 ATP12A

5.42e-05186183d75fe7640a4b2c450c9759a1b3c3ef2a087f0092
ToppCellIPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class

MTUS1 MUC4 ATP12A

5.77e-05190183e41dd5a997ad9952810ffecb57737c03ea1d88b3
ToppCellCOVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations)

MTUS1 MUC4 ATP12A

5.77e-0519018351ca9ef4df3220487152fcf684147730637c7cc1
ToppCellIPF-Epithelial-Goblet|World / Disease state, Lineage and Cell class

MTUS1 MUC4 ATP12A

5.77e-05190183c29dabf0826663b9d6df51a7af9b76592090e44c
ToppCellControl-Epithelial-Basal/Club|Control / Disease group,lineage and cell class （2021.01.30）

RGS7BP MUC4 ATP12A

5.77e-05190183799b0b1c4bdbe04ee0fc34d0be9e02b5992774a0
ToppCellCOPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class

MTUS1 MUC4 ATP12A

5.96e-0519218393b2ca0a97776d28c7e8f1a0642c4b63a5554aab
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

BPTF PCM1 TNRC6A

5.96e-05192183916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

BPTF PCM1 TNRC6A

6.05e-05193183e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RGS7BP MTUS1 PLXND1

6.05e-05193183c0973a2c97deb7176c2f617c8760a55f7edc9839
ToppCellBronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

RGS7BP PSD3 MUC4

6.24e-05195183e7230a849ea31e6eef9bc6f5468938499450582d
ToppCellCOVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class

RGS7BP MUC4 ATP12A

6.33e-05196183dd32046067d93b9484cfbf1d7826a436a3d9f0e9
ToppCellNS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PSD3 MTUS1 MUC4

6.52e-05198183a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d
ToppCell(06)_OLFM4+|World / shred by cell type by condition

PSD3 MTUS1 MUC4

6.62e-05199183c773b9180dbfec9c19d4098dd43332e6f6050372
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster

PSD3 BPTF ROBO2

6.62e-051991831b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster

PSD3 BPTF ROBO2

6.62e-051991834bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCellBiopsy_Control_(H.)-Epithelial-MUC5B+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

RGS7BP MUC4 ATP12A

6.62e-051991834ab45996e6bca406c77895a5998982b8ab1cf210
ToppCellFrontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

PSD3 ATP12A

8.99e-041111821847dde68d349114286bc3317be6339666df4aa2
ToppCellSmart-seq2-blood_(Smart-seq2)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD4-positive,_alpha-beta_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

HSF2 TNRC6A

1.03e-03119182abb7eb746073f3be44a8fab8456b756c1d52b5a3
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Intermediate|GW19 / Sample Type, Dataset, Time_group, and Cell type.

RIOX2 PLXND1

1.05e-03120182eb5b88c47dd4a6f9b55ace24f19d4e81d4ed31e1
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

HSF2 TTF2

1.10e-03123182511b7c20a4a85e49980936d52af7dbca19bb848e
ToppCellTCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma-1|TCGA-Testes / Sample_Type by Project: Shred V9

MUC4 ATP12A

1.31e-03134182d80c9168acbd316761330d29e994e7f9a30ad945
ToppCellClub_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

MUC4 ATP12A

1.38e-03138182133015953fc660d00339f47b415da5e9872313a2
ToppCellTCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma|TCGA-Testes / Sample_Type by Project: Shred V9

MUC4 ATP12A

1.40e-031391826b58d01ce9d9ac23434333f9faf1bb0eef14ba90
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MTUS1 ROBO2

1.57e-0314718264fa0753a3a79f492ef8acc6942bf90d379a983f
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MTUS1 MUC4

1.59e-031481829fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c
ToppCellpdx-Tumor_cells-T4|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

RGS7BP MUC4

1.67e-031521827ccc56b79c499dd48dab8e2d936edca5223b9356
ToppCellChildren_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

MUC4 ATP12A

1.67e-031521821b2a39ae159e79f1fb18d6d164bd7acab5299fca
ToppCellPND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NUP43 PLXND1

1.72e-03154182e3a8a1e63ab345de62bd2e5e54342b00f04ae422
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RGS7BP PLXND1

1.74e-03155182babcb9e548f04ace8157d506d27c5941c692c491
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

PSD3 ROBO2

1.76e-031561827e6805ebc7bc2f9c5965321d16922c155719970f
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like-IPs_and_early_cortical_neurons|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

PSD3 ROBO2

1.76e-03156182741de05295b2d012ac8576378f37709a97c8fb50
ToppCellTransplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

MUC4 ATP12A

1.81e-0315818203281e87780e3bacd089903383c016d03c373bf7
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC4 ATP12A

1.83e-0315918260b1f4dce2ce0911160fda17f137c064da31e2eb
ToppCellfacs-Marrow-T-cells-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HSF2 USP42

1.85e-03160182b3f7ef7e682b48a83ca425f5c439336e96168300
ToppCellClub_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id

MUC4 ATP12A

1.88e-03161182bd08a23b415617f6e8748ed2668d578a860ecf91
ToppCellChildren_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

MUC4 ATP12A

1.88e-031611822d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ROBO2 ATP12A

1.88e-031611827c9d4410d7142a5f3a05418c994f69978c9ffa17
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PSD3 ATP12A

1.88e-03161182176a4a72bb4892932da3c834d1fea5e211847f92
ToppCellLPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RGS7BP TTF2

1.92e-031631825285318c52aa31c9b22dc2ffff078e32e408604d
ToppCellBAL-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters

USP42 NUP43

1.92e-031631827047d3ba847930f42a6d5f71e18d49f3071c6409
ToppCellAdult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor

MUC4 ATP12A

1.94e-031641826e6aedb61f8e195d52e028fdda750a29bb14e57e
ToppCellfacs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ROBO2 ATP12A

1.97e-03165182c746bb22ef52d7f7fa6ee9c37ae6bbe0ccce718e
ToppCellfacs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ROBO2 ATP12A

1.97e-031651824cdd80580d5638fd649280ba3893251c2f898f3f
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RGS7BP PLXND1

1.97e-031651826a621b300442c52adfc15b61d3a6d3a3cb00099f
ToppCellClub_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

MUC4 ATP12A

1.99e-03166182a440aa338aa0c6cd0b5800dfa7e83f8ca16fce1a
ToppCellClub_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id

MUC4 ATP12A

2.02e-03167182dbdaaeb3bd9139cb008d9fe24ec031fc5628f136
ToppCellAdult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor

MUC4 ATP12A

2.02e-031671826efbb2ef6adc8da5dd67210969f825f5cc8ed022
ToppCell356C-Myeloid-Dendritic-cDC_activated|356C / Donor, Lineage, Cell class and subclass (all cells)

PSD3 CD1B

2.02e-0316718243a9375fdbafd7450c553e4620e21537e08639dd
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MUC4 CD1B

2.02e-03167182ecdbfde870a2a44c44b9dd65a8737afc6fbf816c
ToppCellClub_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id

MUC4 ATP12A

2.06e-0316918203b303af8a26c6ff196507fe24f5bd3d75d7b1af
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass

MTUS1 MUC4

2.06e-03169182625788d86f0ceebcf2653a251db1f1a9f9746d29
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC4 ATP12A

2.06e-0316918240b557549fe08c5dc9dba359af35993d68d1640a
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RGS7BP ATP12A

2.06e-031691821a684471dbda42e1470e5a889648666e14f25982
ToppCellNS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

RIOX2 MUC4

2.06e-03169182aec97583b23112060437b619cb429dc32f29285f
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RGS7BP ATP12A

2.06e-03169182db73dae011ff3749b3706e50ab46d03b775dd6bb
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PSD3 MUC4

2.06e-031691822a21f2cef959526bfe3c8f081f4f7e9dd4e01a37
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RGS7BP ATP12A

2.06e-0316918297b7047b87ce0052d8580565c9b44fd2aa6f0d5c
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PSD3 MUC4

2.09e-03170182cc66ac6846c58be9493eb270644ee3ce0f86cfea
ToppCellfacs-Lung-3m-Epithelial-airway_epithelial-club_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MTUS1 MUC4

2.09e-031701826de3778e8257c3330db0780c59238ca501fe5059
ToppCellfacs-Lung-3m-Epithelial-airway_epithelial-club_cell-club_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MTUS1 MUC4

2.09e-0317018260887da674ef1a735bad618235608312d8de63d3
ToppCellILEUM-non-inflamed-(3)_mature_DC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

PSD3 CD1B

2.09e-0317018260151394460e6f27a42fab434e8b7b2adc78b128
ToppCellTCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9

MTUS1 MUC4

2.11e-03171182adbcfa4bf6bc1c604535a24435924cdb091e2dd7
ToppCellP15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

NUP43 TTF2

2.14e-031721827c238a7375341d4647ba7274d93fddfb6fae7ce4
ToppCellwk_08-11-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

PSD3 ROBO2

2.14e-03172182415d57aa6278b8c12e7a2cf9c3fa5283389fb9b0
ToppCellPND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RGS7BP NUP43

2.16e-0317318203b50b2376d353748a32bf14a9fc8341ea61dbca
ToppCellwk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

MUC4 ATP12A

2.16e-03173182d1e47c87bd4750801f3531f66a56c5dccb4ea64c
ToppCellPND28-Endothelial-Endothelial_lymphatic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RGS7BP NUP43

2.16e-031731822978c744d3c8dcaa2b9bb225abf846f82e8f9176
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PSD3 CD1B

2.16e-0317318209a13407a41ff2cba82fc417b72bf9a24ce6c42e
ToppCellPND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RGS7BP NUP43

2.16e-0317318212da47b90aecedaa31764ff7ddb853ee39123e9d
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

PSD3 CD1B

2.16e-03173182bfec038a6783f166240da4861e100643c6ea80a5
ToppCell367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|367C / Donor, Lineage, Cell class and subclass (all cells)

MUC4 ATP12A

2.16e-03173182d8e965ff7e9b758876ec1521c1ccedd739e8d673
ToppCellChildren_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

MUC4 ATP12A

2.16e-03173182464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCellPND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RGS7BP NUP43

2.16e-0317318223d4a315a0ad5c6fc77bcfc18b6c1ff55be99e8f
ToppCell367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|367C / Donor, Lineage, Cell class and subclass (all cells)

MUC4 ATP12A

2.16e-03173182c2d973356c40e0284fd3bd7733a164b141c66008
ToppCelldroplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS7BP TTF2

2.16e-031731829dc7746a84f0e268a7c061e1bbcd5e31903034dc
ToppCellAdult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor

RGS7BP ATP12A

2.18e-031741827d2f802f493f19a068e097b2909a9000e2160266
ToppCellwk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

MUC4 ATP12A

2.18e-031741829e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RGS7BP ATP12A

2.18e-031741823f0a5ce074675d57d479fa069385a1b3071e884e
ToppCellfacs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS7BP PLXND1

2.21e-03175182c1e082538f31b5c98ac63f71dcca4a1211a14708
ToppCellfacs-Mammary_Gland-Mammary_Gland-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS7BP PLXND1

2.21e-031751822f9b5bdf8a62e8e99d1c4f677a8e5525bfd3b4ce
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC4 ATP12A

2.21e-031751828252ddc2ca95071381f0354aefb70c4714828491
DrugLobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; PC3; HT_HG-U133A

MTUS1 BAZ2A PCM1 PLXND1

1.31e-051901845080_DN
DrugMetaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A

HSF2 MTUS1 BAZ2A PLXND1

1.45e-051951843669_UP
DrugThioguanosine [85-31-4]; Down 200; 12.6uM; PC3; HT_HG-U133A

RIOX2 PSD3 MTUS1 BPTF

1.45e-051951846643_DN
DrugBetazole hydrochloride; Down 200; 27uM; HL60; HT_HG-U133A

RIOX2 TTF2 PCM1 PLXND1

1.48e-051961841854_DN
DrugFludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A

RBM5 BAZ2A PCM1 PLXND1

1.54e-051981843785_DN
DrugZoxazolamine [61-80-3]; Up 200; 23.8uM; PC3; HT_HG-U133A

HSF2 BAZ2A PCM1 PLXND1

1.54e-051981846290_UP
DrugGliclazide [21187-98-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A

PSD3 RBM5 BAZ2A MUC4

1.57e-051991842870_UP
Druggp120 protein, Human immunodeficiency virus 1

BPTF ROBO2

2.53e-0430182ctd:C514793
DrugLanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A

HSF2 RBM5 BAZ2A

2.77e-041641833852_UP
DrugHelveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A

HSF2 RBM5 BAZ2A

2.82e-041651833851_UP
DrugDigoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A

HSF2 RBM5 BAZ2A

2.87e-041661835324_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A

RIOX2 RBM5 BPTF

3.75e-041821831891_DN
DrugAzaguanine-8 [134-58-7]; Down 200; 26.2uM; HL60; HT_HG-U133A

RIOX2 TTF2 BPTF

3.94e-041851831833_DN
DrugMetaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A

PSD3 BAZ2A PLXND1

4.06e-041871837368_UP
DrugMometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A

PSD3 MTUS1 PCM1

4.13e-041881835116_DN
DrugKetanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A

PSD3 MTUS1 BAZ2A

4.19e-041891836649_DN
Drugcarbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

PSD3 RBM5 PCM1

4.26e-04190183952_UP
DrugDeltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A

PSD3 PCM1 PLXND1

4.26e-041901834306_DN
DrugAmpyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A

PSD3 MTUS1 BAZ2A

4.26e-041901834507_DN
DrugDaunorubicin hydrochloride [23541-50-6]; Down 200; 7uM; MCF7; HT_HG-U133A

HSF2 RBM5 BPTF

4.26e-041901834983_DN
DrugPempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A

PSD3 RBM5 MTUS1

4.26e-041901834307_DN
DrugProchlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; HL60; HT_HG-U133A

HSF2 MTUS1 PCM1

4.26e-041901831286_UP
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

RIOX2 RBM5 BPTF

4.32e-041911837503_DN
DrugNorgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A

PSD3 MTUS1 TTF2

4.32e-041911834269_DN
DrugDrofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A

RBM5 BAZ2A PLXND1

4.32e-041911836776_UP
DrugFlunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A

PSD3 RBM5 MTUS1

4.32e-041911834273_DN
DrugCarbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A

PSD3 MTUS1 PCM1

4.39e-041921834110_DN
DrugPronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A

PSD3 MTUS1 PCM1

4.39e-041921834104_DN
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A

PSD3 MTUS1 BAZ2A

4.39e-041921832450_UP
DrugFenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A

PSD3 RBM5 MTUS1

4.39e-041921834274_DN
DrugMeclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A

PSD3 MTUS1 PCM1

4.39e-041921834268_DN
DrugN-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A

PSD3 RBM5 PCM1

4.39e-041921834311_DN
DrugLovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A

HSF2 RBM5 MUC4

4.46e-041931834978_UP
DrugMedrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A

PSD3 RBM5 PCM1

4.52e-041941834727_DN
DrugFlumequine [42835-25-6]; Down 200; 15.4uM; PC3; HT_HG-U133A

HSF2 MTUS1 PCM1

4.52e-041941835104_DN
DrugMoxalactam disodium salt [64953-12-4]; Down 200; 7uM; PC3; HT_HG-U133A

HSF2 MTUS1 PCM1

4.52e-041941834648_DN
DrugScopoletin [92-61-5]; Up 200; 20.8uM; MCF7; HT_HG-U133A

HSF2 PSD3 BAZ2A

4.52e-041941836510_UP
DrugProcainamide hydrochloride [614-39-1]; Down 200; 14.8uM; PC3; HT_HG-U133A

RBM5 MTUS1 PCM1

4.52e-041941834602_DN
DrugSB 202190; Down 200; 1uM; PC3; HT_HG-U133A

HSF2 PSD3 RBM5

4.59e-041951837058_DN
DrugPerphenazine [58-39-9]; Down 200; 10uM; PC3; HG-U133A

NUP43 BAZ2A PCM1

4.59e-041951831956_DN
DrugIndapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A

HSF2 RBM5 BAZ2A

4.59e-041951833778_DN
DrugSulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A

PSD3 RBM5 PCM1

4.59e-041951836101_DN
DrugMedrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A

HSF2 MTUS1 PCM1

4.59e-041951833705_DN
DrugMethionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; HL60; HT_HG-U133A

MTUS1 BAZ2A PCM1

4.59e-041951832470_DN
DrugGabazine [105538-73-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A

RBM5 MTUS1 BAZ2A

4.59e-041951834820_DN
DrugRapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A

RIOX2 RBM5 PCM1

4.59e-041951831207_DN
DrugGabexate mesilate [56974-61-9]; Down 200; 9.6uM; PC3; HT_HG-U133A

MTUS1 PCM1 PLXND1

4.59e-041951834220_DN
DrugOxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A

HSF2 RBM5 BAZ2A

4.59e-041951834969_UP
DrugButoconazole nitrate [32872-77-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A

PSD3 BAZ2A PLXND1

4.59e-041951835388_DN
DrugN-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A

RBM5 MTUS1 PCM1

4.59e-041951833755_DN
DrugNafcillin sodium salt monohydrate [7177-50-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A

RBM5 BAZ2A PCM1

4.59e-041951834103_DN
DrugRonidazole [7681-76-7]; Up 200; 20uM; PC3; HT_HG-U133A

HSF2 BAZ2A MUC4

4.66e-041961837131_UP
DrugDinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A

PSD3 RBM5 PLXND1

4.66e-041961835409_DN
DrugPropafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; MCF7; HT_HG-U133A

PSD3 BAZ2A ATP12A

4.66e-041961832871_UP
DrugPizotifen malate [5189-11-7]; Down 200; 9.4uM; HL60; HT_HG-U133A

MTUS1 BAZ2A PLXND1

4.66e-041961833134_DN
Drugestradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A

PSD3 RBM5 BAZ2A

4.66e-041961835568_DN
DrugPF-00539745-00 [351321-33-0]; Down 200; 10uM; MCF7; HT_HG-U133A

RBM5 MUC4 PCM1

4.66e-041961835974_DN
Drug(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A

HSF2 PCM1 PLXND1

4.66e-041961833789_DN
DrugDobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

RBM5 BAZ2A PCM1

4.66e-041961833206_DN
DrugEdrophonium chloride [116-38-1]; Down 200; 19.8uM; PC3; HG-U133A

RBM5 BAZ2A TTF2

4.66e-041961831936_DN
DrugTriprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A

PSD3 BAZ2A TTF2

4.66e-041961837408_UP
DrugEpicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A

BAZ2A PCM1 PLXND1

4.66e-041961834594_DN
DrugNicergoline; Up 200; 8.2uM; PC3; HT_HG-U133A

PSD3 MTUS1 PCM1

4.66e-041961832058_UP
DrugFludrocortisone acetate [514-36-3]; Up 200; 9.4uM; PC3; HT_HG-U133A

BAZ2A CD1B PLXND1

4.66e-041961834342_UP
DrugClidinium bromide [3485-62-9]; Down 200; 9.2uM; HL60; HT_HG-U133A

PSD3 RBM5 MTUS1

4.73e-041971832734_DN
DrugArecoline hydrobromide [300-08-3]; Up 200; 17uM; MCF7; HT_HG-U133A

RBM5 BAZ2A PCM1

4.73e-041971832657_UP
DrugAndrosterone [53-41-8]; Up 200; 13.8uM; HL60; HT_HG-U133A

PSD3 MTUS1 PCM1

4.73e-041971831296_UP
Drugforskolin; Down 200; 50uM; HL60; HG-U133A

NUP43 TTF2 BPTF

4.73e-04197183783_DN
Druggenistein; Down 200; 10uM; MCF7; HT_HG-U133A

HSF2 RBM5 PLXND1

4.73e-041971836952_DN
DrugIndoprofen [31842-01-0]; Down 200; 14.2uM; MCF7; HT_HG-U133A

HSF2 BAZ2A PCM1

4.73e-041971834832_DN
DrugTriamcinolone [124-94-7]; Down 200; 10.2uM; HL60; HG-U133A

BAZ2A TTF2 PCM1

4.73e-041971831395_DN
DrugFendiline hydrochloride [13636-18-5]; Down 200; 11.4uM; HL60; HG-U133A

BAZ2A TTF2 PCM1

4.73e-041971831573_DN
DrugRaloxifene hydrochloride [82640-04-8]; Down 200; 7.8uM; HL60; HT_HG-U133A

PSD3 MTUS1 PCM1

4.73e-041971832738_DN
DrugICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A

PSD3 MTUS1 BAZ2A

4.73e-041971832665_UP
DrugAmoxapine [14028-44-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A

HSF2 PSD3 RBM5

4.73e-041971831513_UP
DrugSulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A

HSF2 BAZ2A PCM1

4.73e-041971836230_DN
DrugIfenprodil tartrate [23210-58-4]; Down 200; 8.4uM; PC3; HT_HG-U133A

MTUS1 BAZ2A PCM1

4.73e-041971835044_DN
DrugTerbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A

PSD3 MTUS1 PCM1

4.73e-041971836240_DN
DrugTenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A

RBM5 MTUS1 BAZ2A

4.73e-041971832860_UP
DrugEpirizole [18694-40-1]; Up 200; 17uM; PC3; HT_HG-U133A

MTUS1 BAZ2A PLXND1

4.73e-041971837292_UP
Drug2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A

HSF2 MTUS1 BAZ2A

4.73e-041971836934_DN
DrugVerapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; HL60; HG-U133A

HSF2 RBM5 PCM1

4.73e-041971832009_UP
DrugIobenguane sulfate; Down 200; 10.8uM; PC3; HT_HG-U133A

PSD3 MTUS1 PCM1

4.80e-041981837299_DN
DrugZalcitabine [7481-89-2]; Down 200; 19uM; PC3; HT_HG-U133A

MTUS1 PCM1 PLXND1

4.80e-041981834215_DN
DrugDipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A

HSF2 RBM5 PCM1

4.80e-041981833754_DN
DrugLomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; HL60; HT_HG-U133A

BAZ2A PCM1 PLXND1

4.80e-041981832348_DN
Drug5155877; Down 200; 10uM; PC3; HT_HG-U133A

PSD3 BAZ2A PCM1

4.80e-041981836569_DN
DrugIsradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A

HSF2 PSD3 MTUS1

4.80e-041981836508_DN
Drugvinblastine sulfate; Down 200; 0.1uM; MCF7; HT_HG-U133A

PSD3 BAZ2A PCM1

4.80e-041981837517_DN
DrugGlycopyrrolate [596-51-0]; Up 200; 10uM; PC3; HT_HG-U133A

HSF2 PSD3 MTUS1

4.80e-041981837386_UP
DrugDiperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A

BAZ2A PCM1 PLXND1

4.80e-041981834498_DN
DrugAztreonam [78110-38-0]; Down 200; 9.2uM; PC3; HT_HG-U133A

PSD3 MTUS1 PCM1

4.80e-041981835110_DN
DrugEvoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A

HSF2 PSD3 PCM1

4.80e-041981834704_DN
DrugCholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A

PSD3 BAZ2A PLXND1

4.80e-041981835002_UP
DrugUrosiol [128-13-2]; Up 200; 10.2uM; PC3; HT_HG-U133A

PSD3 MTUS1 PCM1

4.80e-041981837243_UP
DrugAcetazolamide [59-66-5]; Up 200; 18uM; HL60; HT_HG-U133A

PSD3 RBM5 MTUS1

4.80e-041981831850_UP
DrugAdiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT_HG-U133A

MTUS1 BAZ2A PCM1

4.80e-041981837279_UP
DrugAmoxicillin [26787-78-0]; Up 200; 11uM; HL60; HT_HG-U133A

MTUS1 BAZ2A PCM1

4.80e-041981831265_UP
Drugtetraethylenepentamine pentahydrochloride; Down 200; 100uM; ssMCF7; HG-U133A

MTUS1 BAZ2A PLXND1

4.87e-04199183498_DN
DrugSulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A

RBM5 MTUS1 BAZ2A

4.87e-041991836036_DN
Diseasemetabolic syndrome

PSD3 BPTF TNRC6A

2.32e-04200183EFO_0000195
Diseasebrain measurement, neuroimaging measurement

NUP43 BPTF ROBO2 TNRC6A

2.97e-04550184EFO_0004346, EFO_0004464
Diseasetriglycerides in LDL measurement

PSD3 BPTF

5.31e-0456182EFO_0022320
Diseasetriglycerides in medium LDL measurement

PSD3 BPTF

6.50e-0462182EFO_0022322
Diseasetriglycerides in small LDL measurement

PSD3 BPTF

7.15e-0465182EFO_0022323
Diseasetriglycerides in very small VLDL measurement

PSD3 BPTF

7.82e-0468182EFO_0022144
Diseasegrip strength measurement

BPTF ROBO2 TNRC6A

1.18e-03350183EFO_0006941
Diseaselymphocyte count

HSF2 PSD3 TTF2 ROBO2 PLXND1

1.49e-031464185EFO_0004587
Diseasebone density

PSD3 TTF2 PLXND1

1.59e-03388183EFO_0003923
Diseasecomparative body size at age 10, self-reported

RGS7BP ROBO2 TNRC6A

1.99e-03420183EFO_0009819
Diseasetriglyceride measurement, intermediate density lipoprotein measurement

PSD3 BPTF

2.06e-03111182EFO_0004530, EFO_0008595
Diseaseimmature platelet fraction

PSD3 BAZ2A

2.17e-03114182EFO_0009187
Diseasevisceral adipose tissue measurement

BPTF ROBO2 TNRC6A

2.93e-03481183EFO_0004765
Diseasemean platelet volume

PSD3 BAZ2A PLXND1 TNRC6A

2.95e-031020184EFO_0004584
Diseasemean arterial pressure

RGS7BP TNRC6A ATP12A

3.25e-03499183EFO_0006340
Diseasetriglyceride measurement, phospholipid measurement

PSD3 BPTF

3.53e-03146182EFO_0004530, EFO_0004639
Diseasetriglyceride measurement, low density lipoprotein cholesterol measurement

PSD3 BPTF

4.54e-03166182EFO_0004530, EFO_0004611
Diseaselung adenocarcinoma

MTUS1 BPTF

4.97e-03174182EFO_0000571
Diseaseheel bone mineral density, urate measurement

PSD3 PCM1

5.42e-03182182EFO_0004531, EFO_0009270
Diseasemacula measurement

BPTF TNRC6A

5.84e-03189182EFO_0008375
DiseaseProstatic Neoplasms

BAZ2A MUC4 ROBO2

5.85e-03616183C0033578
DiseaseMalignant neoplasm of prostate

BAZ2A MUC4 ROBO2

5.85e-03616183C0376358
Diseasebody weight

RGS7BP BPTF PCM1 TNRC6A

6.28e-031261184EFO_0004338
Diseasetriglycerides:total lipids ratio, high density lipoprotein cholesterol measurement

PSD3 BPTF

6.89e-03206182EFO_0004612, EFO_0020947
Diseasefree cholesterol measurement, very low density lipoprotein cholesterol measurement

PSD3 BPTF

7.49e-03215182EFO_0008317, EFO_0008591
Diseasevery low density lipoprotein cholesterol measurement, lipid measurement

PSD3 BPTF

7.83e-03220182EFO_0004529, EFO_0008317

Protein segments in the cluster

PeptideGeneStartEntry
QSAFLSWLSQTQSHS

BAZ2A

1266

Q9UIF9
IQTSSFTNSTWAQTQ

CD1B

31

P29016
HQTFATWVKQGQSNS

BPTF

2111

Q12830
NQTLSVNQQWTTAHY

NUP43

106

Q8NFH3
ISNQANVHQSVISSW

NUP43

316

Q8NFH3
SSSSPVDSQQHSWQV

RGS7BP

181

Q6MZT1
TSIQDTSASSQNHWT

MUC4

186

Q99102
TQNSSASSVNWNSAN

MTUS1

36

Q9ULD2
HSNQVFDQSSRTWAS

ATP12A

421

P54707
TWNEVNSHSNAQCVS

PCM1

556

Q15154
CTNSSQQHFWTSASE

PLXND1

581

Q9Y4D7
TAIAAAQWSSTQSQS

RBM5

336

P52756
THTNEFITWSQNGQS

HSF2

21

Q03933
VNASASVQNWSVNRS

USP42

496

Q9H9J4
SQSVSNSWQTVANHV

ROBO2

561

Q9HCK4
STHVTISTYQNNSWG

RIOX2

251

Q8IUF8
FVWVNNASAHSQSVA

PSD3

11

Q9NYI0
SATSQTNEQSSVWAK

TNRC6A

651

Q8NDV7
NSASQKSVIVSQWTN

TTF2

1006

Q9UNY4